Connect with us

Business

Why Marquie Group Inc (OTCMKTS:TMGI) May Surprise as a Speculative Star in the Making

Published

on

The CBD space has been stirring with an energy of rebounding sentiment so far in 2020, and one stock that may be positioned to benefit in dramatic fashion is Marquie Group Inc (OTCMKTS:TMGI).

What we like here is the fact that this one has more going in its favor than just the simple fact of involvement in the CBD theme. There are just too many CBD plays and we have developed a “tragedy of the commons” crowded theme narrative at this point. It may be bottoming in that fashion already, but it has already been a brutal ride for most of these stocks.

TMGI is different

This is a company targeting the health and beauty marketplace. And the x-factor here is Jacquie Carter Angell, who has been something of an all-star in the health and beauty market for two decades. She has established an internationally recognized personal brand as a beauty expert, appearing in television, radio, magazine, newspaper and media events around the world, and partnering with celebrities, Olympic athletes, doctors, nutritionists and a Nobel Prize laureate in brand-building and marketing health and beauty products to women in more than 90 countries.

Her specific power has been product development with a focus on the female consumer in the 35-49 age bracket. This specialty pushed her all the way to international director at Herbalife Nutrition, where she drove product development with great success before leaving to take the captain’s seat at The Marquie Group.

Now, in this new role, and with the world watching, the company just announced the upcoming release of a line of CBD tinctures in the weeks ahead, built from the ground up with a focus on differentiation through consumer experience.

There are two major problems for CBD companies right now: no plan for differentiation and no sense of target marketing. TMGI is entering this explosive space with unique and very plausible answers to both of those questions.

“The CBD market presents an excellent revenue opportunity for us because of the rapid growth rate defining the industry over the past two years. We’re a company that knows how to design products for women in the 35 to 49 age group, which is the largest demographic in the CBD marketplace,” stated Jacquie Carter Angell, president of The Marquie Group.

Hand Meet Glove

Marquie Group Inc (OTCMKTS:TMGI) bills itself as company directly targeting the CBD market for women in the 35-49 years range. The big edge here is its president, as noted.

And it just so happens that the women 35-49 demo is the most prolific in the rapidly growing CBD marketplace.

TMGI is a direct-to-consumer health and beauty products platform with a pipeline of innovative solutions to pervasive wellness concerns: anxiety, anti-aging, low energy, sleeplessness, and stress that use advanced formulations of plant-based, amino-acids and CBD alternatives to chemical ingredients.

All products will feature unique formulations of top-quality ingredients meant to impart skin health that comes from improved amino-acid balance and CBD nutrition.

Products planned for a 2020 launch include facial skin care serums, a powerful amino acid infused collagen drink and custom blended CBD tinctures each with their own potent puree of nature’s finest fruits, flowers and herbs. Each one is uniquely developed to provide optimal sleep and relaxation, mental focus and clarity or beauty and antioxidant benefits via an array of plant- based ingredients formulated to enhance one’s Inner Health and Outer Beauty.

Now commanding a market cap of $1.2M, TMGI is cheap and already pulling in trailing revenues. The company’s current push suggests top-line growth is overwhelmingly likely over the near and intermediate-term as it approaches the primary launch of its health and beauty platform in coming weeks.

As more color becomes clear on the name, we will review the situation and update our take.

 

This article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business23 hours ago

Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada

Post Views: 115 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...

Business2 days ago

Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets

Post Views: 146 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...

Business2 days ago

1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada

Post Views: 134 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...

Business3 days ago

Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe

Post Views: 63 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...

INDUSTRIAL HEMP3 days ago

Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA

Post Views: 198 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...

Business6 days ago

cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA

Post Views: 310 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...